# Modulation of Microbial Composition in Ileostomy Patients

> **NCT02920294** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Ileostomy - Stoma

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic 1
- **DIETARY_SUPPLEMENT:** Probiotic 2
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02920294
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-11-11
- **Final completion:** 2017-11-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02920294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02920294, "Modulation of Microbial Composition in Ileostomy Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02920294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*